News
Click buys Better assets to speed its digital obesity drive
Click Therapeutics has snapped up the assets of troubled digital …
19725 items found
Market Access
Rare diseases: the urgent need for health equity and accelerated access
Rare diseases are complex, but the need is urgent. Alexion’s Eunice …
News
Tony Blair Institute weighs in on use of NHS patient data
A think tank set up by former UK Prime Minister Tony Blair has called …
Market Access
NICE and the controversy over a ‘clinically distinct disease’ designation
Payers worldwide are struggling with a new generation of precision …
News
US senators accuse pharma firms of abusing patent system
Lawmakers across the political divide have accused the pharma …
News
Judge says Ultragenyx must face Henrietta Lacks estate suit
An attempt by Ultragenyx to have a lawsuit filed by the family of …
Digital
Sponsored
Digital health innovation: Applications across the patient journey
Digital health innovation (DHI) is a growing category of technologies …
News
Immune checkpoint enhancer biotech AltruBio raises $225m
A healthy run of nine-figure private rounds for biotechs in the US …
News
GSK’s twice-yearly asthma drug clears two phase 3 trials
GSK’s follow-up to its severe asthma therapy Nucala has shown its …
R&D
Plants and vaccine adjuvants: BSI’s sustainable trees in a lab
This time last year, Croda Pharma and Botanical Solution Inc (BSI) …
News
AstraZeneca sets lofty target of $80bn in revenues by 2030
AstraZeneca easily delivered on chief executive Pascal Soriot’s …
News
Internal budgets ‘holding back pharma’s digital evolution’
Digital investment in the pharma sector is continuing at a steady …
News
WhatsApp lands Moderna in hot water with PMCPA
A WhatsApp message has earned Moderna a reprimand from the UK's Prescription Medicines Code of Practice Authority (PMCPA), with Novo Nordisk, Otsuka, AstraZeneca, and Daiichi Sankyo also fo
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
Access to genomic surveillance: Open science and public heal...
The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
Patients
Partner Content
How walking in a patient's shoes adds value to your patient ...
Imagine the difference it would make if everyone in your organisation had firsthand experience of living with one of the conditions you help treat. What insights would you gain?
R&D
Partner Content
BIO-Europe's 30th Anniversary Landmark Event in Stockholm
BIO-Europe™ celebrates 30 years of facilitating partnerships this Fall. In 1994, BIO-Europe launched with the mission to drive biotech innovation and
